Drug record
What four public record sets show for gabapentin. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.022 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $610.9 million | Details |
| FDA recall records | 25 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Gabapentin 100 Mg Capsule: pharmacies pay about $0.022 each, or $0.658 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| GABAPENTIN 100 MG CAPSULE | Generic | $0.022 per each | $0.658 | Oct 28, 2026 |
| GABAPENTIN 250 MG/5 ML SOLN | Generic | $0.084 per mL | — | Oct 21, 2026 |
| GABAPENTIN 300 MG CAPSULE | Generic | $0.033 per each | $0.985 | Oct 28, 2026 |
| GABAPENTIN 400 MG CAPSULE | Generic | $0.043 per each | $1.29 | Oct 21, 2026 |
| GABAPENTIN 600 MG TABLET | Generic | $0.064 per each | $1.92 | Oct 21, 2026 |
| GABAPENTIN 800 MG TABLET | Generic | $0.086 per each | $2.58 | Oct 21, 2026 |
| GABAPENTIN ER 300 MG TABLET | Generic | $0.623 per each | $18.68 | Oct 21, 2026 |
| GABAPENTIN ER 600 MG TABLET | Generic | $1.11 per each | $33.19 | Oct 21, 2026 |
| GRALISE ER 300 MG TABLET | Brand | $10.20 per each | $306.00 | Oct 21, 2026 |
| GRALISE ER 450 MG TABLET | Brand | $10.14 per each | $304.28 | Dec 17, 2025 |
| GRALISE ER 600 MG TABLET | Brand | $10.15 per each | $304.59 | Oct 21, 2026 |
| GRALISE ER 900 MG TABLET | Brand | $15.28 per each | $458.43 | Oct 21, 2026 |
| HORIZANT ER 300 MG TABLET | Brand | $17.93 per each | $537.96 | Oct 21, 2026 |
| HORIZANT ER 600 MG TABLET | Brand | $17.91 per each | $537.28 | Oct 21, 2026 |
| NEURONTIN 100 MG CAPSULE | Brand | $2.96 per each | $88.70 | Oct 21, 2026 |
| NEURONTIN 300 MG CAPSULE | Brand | $7.36 per each | $220.94 | Oct 21, 2026 |
| NEURONTIN 400 MG CAPSULE | Brand | $8.87 per each | $266.02 | Jan 1, 2026 |
| NEURONTIN 600 MG TABLET | Brand | $14.11 per each | $423.37 | Oct 21, 2026 |
| NEURONTIN 800 MG TABLET | Brand | $16.88 per each | $506.44 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $610.9 million for the 5 products below. That is down 9% from $673.9 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Gabapentin Gabapentin | $544.2 million | 7,960,881 | $14.78 | $68.35 | $618.4 million |
| Horizant Gabapentin Enacarbil | $31.8 million | 5,984 | $1,102.28 | $5,320.37 | $29.9 million |
| Neurontin Gabapentin | $18.6 million | 2,346 | $1,578.20 | $7,911.20 | $25.6 million |
| Gralise Gabapentin | $12.5 million | 2,970 | $994.51 | $4,211.10 | — |
| Gabapentin ER Gabapentin | $3.9 million | 2,749 | $478.63 | $1,405.60 | — |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 25 recall records that name gabapentin in the product description (18 Class II · 7 Class III). 7 are still marked ongoing.
Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61 (Blister pack), NDC 55154-3363-0 (Outer Bag).
Reason: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Gabapentin Capsules, USP, 100 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-6665-61
Reason: Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .
Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61
Reason: Defective container; blister packaging inadequately sealed.
Gabapentin Capsules, USP, 100 mg, 10 capsules (10x1) per bag, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-3363-0
Reason: Defective container; blister packaging inadequately sealed.
Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-126-05.
Reason: CGMP Deviations
Gabapentin Capsules, USP 400 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-139-05; b) 1000-count bottles, NDC 62756-139-04; Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Reason: Cross Contamination
Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.
Reason: Cross Contamination
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05
Reason: Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
Gabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. East Windsor, NJ 08520 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA, NDC 0904-6823-61
Reason: Product mixup: one foreign tablet found in product.
Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
Reason: Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.
Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07
Reason: Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing
Gabapentin Tablets USP, 600 mg, Rx Only, 500-count bottle, Manufactured for: Exelan Pharmaceuticals, Inc., Lawrenceville, GA 30046, Manufactured by: InvaGen Pharmaceuticals, Inc., Hauppauge, NY 11788, NDC 76282-405-05.
Reason: Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for gabapentin. This page is public-record information, not medical advice.